Interim analyses in clinical trials: why do we plan them?
- PMID: 11118460
- DOI: 10.1200/JCO.2000.18.24.4007
Interim analyses in clinical trials: why do we plan them?
Comment on
-
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer.J Clin Oncol. 2000 Dec 15;18(24):4009-15. doi: 10.1200/JCO.2000.18.24.4009. J Clin Oncol. 2000. PMID: 11118461 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical